The clinical trial remains our best tool to identify new therapies, but as with all tools, innovation is required if trials are to remain relevant.
Paul Sabbatini, MD, is a medical oncologist caring for women with ovarian cancer. In his role as Deputy Physician-in-Chief for Clinical Research he is responsible for developing and expanding Memorial Sloan-Kettering's clinical research program.